<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Adinda De Schrijver</style></author><author><style face="normal" font="default" size="100%">Y. Devos</style></author><author><style face="normal" font="default" size="100%">P. De Clercq</style></author><author><style face="normal" font="default" size="100%">A. Gathmann</style></author><author><style face="normal" font="default" size="100%">J. Romeis</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Minimal quality criteria for acceptability of in vivo bio-assays with Bt-proteins</style></title><secondary-title><style face="normal" font="default" size="100%">ISB News Report</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">May-June </style></volume><pages><style face="normal" font="default" size="100%">1 - 6</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;As part of the regulatory authorization process, the potential risks that the cultivation of genetically engineered (GE) plants may pose to non-target organisms (NTOs) and the ecosystem services they provide are assessed in many jurisdictions. A typical risk hypothesis addressed during the environmental risk assessment (ERA) of&lt;/p&gt;
</style></abstract><custom1><style face="normal" font="default" size="100%">&lt;p&gt;5781&lt;/p&gt;
</style></custom1><section><style face="normal" font="default" size="100%">1</style></section></record></records></xml>